However, no correlation of KIF2A expression with other clinical characteristics including age (P=0.544), gender (P=0.132), FAB classification M1 (P=1.000), FAB classification M4 (P=0.486), FAB classification M5 (P=0.340), FAB classification M6 (P=1.000), cytogenetics (P=0.880), FLT3-ITD mutation (P=0.204), isolated biallelic CEBPA mutation (P=0.808), and NPM1 mutation (P=0.210) was found in AML patients. Here, KIF2A is linked to acute myeloid leukemia.